AAMU
KRTX

Amundi Asset Management US’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Amundi Asset Management US’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$301K Hold
2,500
– – ﹤0.01% 1418
2020
Q4 		$254K Hold
2,500
– – ﹤0.01% 1392
2020
Q3 		$193K Sell
2,500
-100
-4% -$8.52K ﹤0.01% 1389
2020
Q2 		$290K Sell
2,600
-100
-4% -$8.69K ﹤0.01% 1332
2020
Q1 		$194K Buy
+2,700
New +$231K ﹤0.01% 1338

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Amundi Asset Management US's KRTX Position: Q1 2021 in Review

Amundi Asset Management US held its Karuna Therapeutics, Inc. Common Stock (KRTX) position steady in Q1 2021 at 2,500 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Amundi Asset Management US first reported a position in KRTX in Q1 2020 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold KRTX as of Q1 2021.

  • Amundi Asset Management US held 2,500 shares of Karuna Therapeutics, Inc. Common Stock worth $301K as of Q1 2021.
  • Amundi Asset Management US left its Karuna Therapeutics, Inc. Common Stock share count unchanged in Q1 2021.
  • Karuna Therapeutics, Inc. Common Stock made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1418 holding.
  • Amundi Asset Management US first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.